PR Newswire - Financial

TRANSITION Add to My Watchlist

(NSDQ: TTHI)

Detailed Quote

News

Last Price	7.44 (11.20.09 5:20 PM EST)
Change (%)	-0.12 (-1.59%)
Volume	900
Open	7.44
Previous Close	7.56
Day High	7.47
Day Low	7.42
Bid	7.50 x 100
Ask	7.75 x 800

Average Volume	18,835
Shares Outstanding	23.22M
Market Cap	172.7M
Year High	9.00
Year Low	2.00
Earnings Per Share	N/A
P/E Ratio	N/A
Dividend	N/A
Yield	N/A

Intraday

3 Month

6 Month

1 Year

Symbol	Last	Change (%)
CXSPY	17.00	+0.00 (+0.00)
GRO	3.35	+0.00 (+0.00)
CYTK	3.40	-0.05 (-1.45%)
QLTI	3.69	-0.03 (-0.81%)
CVM	1.30	+0.00 (+0.00)
OSUR	4.15	-0.03 (-0.72%)
ASM	0.31	+0.00 (+0.00)

Fri, Aug 07, 2009
	Transition Therapeutics to Present at Canaccord Adams 29th Annual Global Growth Conference - PR Newswire
Thu, Jun 18, 2009
	Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations - PR Newswire
Wed, May 13, 2009
	Transition Therapeutics Announces Third Quarter Fiscal 2009 Financial Results - PR Newswire
Tue, May 12, 2009
	Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2009 Financial Results on Wednesday, May 13th, at 4:30 P.M. EST - PR Newswire
Mon, Mar 23, 2009
	Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes - PR Newswire
More Featured Content

Fri, Nov 20, 2009
	Free-Cash-News releases Free Cash Flow for Transition Therapeutics - StockTrendNews.com f...
	Year over Year Revenue Comparisons for Transition Therapeutics Now Available by T12-NEWS - StockTrendNews.com s...
	Latest CFFO for Transition Therapeutics now available via CFFO-NEWS - StockTrendNews.com c...
	OPS Ranking for Transition Therapeutics released by StockDiagnostics.com - StockTrendNews.com o...
Tue, Sep 29, 2009
	Transition Therapeutics (TTHI) $75 Million Mixed Securities Shelf Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4978348 for the full story. - StreetInsider
More News

Fri, Jun 26, 2009
	Upcoming Clinical Trials data of a small cap company's Alzheimer's drug to be presented in July (TTHI, rated BUY) TTHI is going to be presenting data on their Alzheimer's disease drug (ELND-005) at the Alzheimer's conference in July. If the trials data is positive, it brings the company one step closer to the approval of thier breakthrough treatment for Alzheimer's disease. To find out about the drug, how the drug works, who are the other players developing drugs in this area and how TTHI's drug compares with the rest, read a FREE report of the upcoming trials data at: http://www.newbiomedicine.com - SocialPicks
Fri, Mar 14, 2008
	Premarket Movers UP TRANSITION THERAPEUTICS INC (TTHI) Yahoo! Inc. (YHOO) Exxon Mobil Corporation (XOM) Shire plc (ADR) (SHPGY) Evergreen Solar, Inc. (ESLR) DOWN TICC Capital Corp. (TICC) UCBH Holdings, Inc. (UCBH) Goodrich Petroleum Corporation (GDP) Carnival Corporation (CCL) Micron Technology, Inc. (MU) Swing Trading, Technical Analysis, Daily Stock Market Commentary. - 2dtrading
More Blogs

11/10/09		800-954-0691
09/16/09		800-920-2983
05/13/09		800-926-4420
11/10/08		800-954-1051
09/16/08		800-263-9157

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs